Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BMS-247550 in Metastatic Gastric Adenocarcinoma
NCT00017043Phase 2Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Feb 2001
- Primary completion
- Jan 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of ixabepilone in gastric adenocarcinoma, sponsored by Bristol Myers Squibb. Primary endpoint: Response Rate. Started Feb 2001; status: completed.
02
Drugs
ixabepilone
03
Conditions
gastric adenocarcinoma
Beyond the preview
Go deeper on NCT00017043.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00017043.